Origin of fibrosing cells in systemic sclerosis

Current Opinion in Rheumatology

Volumn 27, Issue 6, 2015, Pages 555-562

  Ebmeier, Sarah ^a   Horsley, Valerie ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosing cell; Fibrosis; Lineage tracing; Myofibroblast; Systemic sclerosis

Indexed keywords

ADIPOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELLS BY BODY ANATOMY; EFFECTOR CELL; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSING CELL; GENE EXPRESSION; HUMAN; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; MYOFIBROBLAST; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SYSTEMIC SCLEROSIS; CONNECTIVE TISSUE CELL; FIBROSIS; MESENCHYMAL STROMA CELL; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOCYTES; CONNECTIVE TISSUE CELLS; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROBLASTS; FIBROSIS; HUMANS; MESENCHYMAL STROMAL CELLS; PERICYTES; SCLERODERMA, SYSTEMIC;

EID: 84942512037     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000217     Document Type: Review

References (84)

1. Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology. Am J Pathol 2012; 180:1340-1355.
2. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27:549-550.
3. Gabbiani G. Dupuytren's contracture: fibroblast contraction?: An ultrastructural study. Am J Pathol 1972; 66:131.
4. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63:21-29.
5. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200:500-503.
6. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1:71.
7. Sidney LE, Branch MJ, Dunphy SE, et al. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 2014; 32:1380-1389.
8. Driskell RR, Lichtenberger BM, Hoste E, et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 2013; 504:277-281.
9. Rinkevich Y, Walmsley GG, Hu MS, et al. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 2015; 348: aaa2151.
10. Asada N, Takase M, Nakamura J, et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121:3981-3990.
11. Kleaveland KR, Velikoff M, Yang J, et al. Fibrocytes are not an essential source of Type I collagen during lung fibrosis. J Immunol 2014; 193:5229-5239.
12. Dulauroy S, Di Carlo SE, Langa F, et al. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18:1262-1270.
13. Göritz C, Dias DO, Tomilin N, et al. A pericyte origin of spinal cord scar tissue. Science 2011; 333:238-242.
14. Birbrair A, Zhang T, Files DC, et al. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther 2014; 5:122.
15. Iwayama T, Steele C, Yao L, et al. PDGFRα signaling drives adipose tissue fibrosis by targeting progenitor cell plasticity. Genes Dev 2015; 29:1106-1119.
16. LeBleu VS, Taduri G, O'Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19:1047-1053.
17. Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176:85-97.
18. Hung C, Linn G, Chow YH, et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013; 188:820-830.
19. Henderson NC, Arnold TD, Katamura Y, et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013; 19:1617-1624.
20. Kramann R, Schneider RK, DiRocco DP, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015; 16:51-66.
21. Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173:1617-1627.
22. Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109:9448-9453.
23. Taura K, Miura K, Iwaisako K, et al. Hepatocytes do not undergo epithelial mesenchymal transition in liver fibrosis in mice. Hepatology 2010; 51:1027-1036.
24. Pessina P, Kharraz Y, Jardí M, et al. Fibrogenic cell plasticity blunts tissue regeneration and aggravates muscular dystrophy. Stem Cell Rep 2015; 4:1046-1060.
25. Higashiyama R, Nakao S, Shibusawa Y, et al. Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J Invest Dermatol 2011; 131:529-536.
26. Marangoni RG, Korman B, Wei J, et al. Myofibroblasts in cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol 2015; 67:1062-1073.
27. Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 2013; 4:2823.
28. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282:23337-23347.
29. Chu AS, Diaz R, Hui JJ, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 2011; 53:1685-1695.
30. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 10:341-350.
31. Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 2011; 108:E1475-E1483.
32. Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMPdependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res 2012; 27:1004-1017.
33. Hashimoto N, Phan SH, Imaizumi K. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43:161-172.
34. Zeisberg EM, Potenta SE, Sugimoto H, et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19:2282-2287.
35. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961.
36. Borie R, Quesnel C, Phin S, et al. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis. PLoS One 2013; 8:e53736.
37. Madala SK, Edukulla R, Schmidt S, et al. Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-αinduced pulmonary fibrosis. Am J Respir Cell Mol Biol 2014; 50:777-786.
38. Andersson-Sjöland A, de Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-2140.
39. Pilling D, Zheng Z, Vakil V, Gomer RH. Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis. Proc Natl Acad Sci U S A 2014; 111:18291-18296.
40. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003; 171:5537-5546.
41. Pilling D, Roife D, Wang M, et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007; 179:4035-4044.
42. Murray LA, Chen Q, Kramer MS, et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 2011; 43:154-162.
43. Murray LA, Rosada R, Moreira AP, et al. Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 2010; 5:e9683.
44. Murray IR, West CC, Hardy WR, et al. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci 2014; 71:1353-1374.
45. Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007; 317:807-810.
46. Joe A, Yi L, Natarajan A, Le Grand F, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12:153-163.
47. Mann CJ, Perdiguero E, Kharraz Y, et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 2011; 1:21.
48. Uezumi A, Fukada S, Yamamoto N, et al. Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 2014; 5:e1186.
49. Uezumi A, Ito T, Morikawa D, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 2011; 124 (Pt 21):3654-3664.
50. Uezumi A, Fukada S, Yamamoto N, et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12:143-152.
51. Rajkumar VS, Howell K, Csiszar K, et al. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther 2005; 7:R1113-R1123.
52. Hellstrom M, Kalén M, Lindahl P, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999; 126:3047-3055.
53. Hellstrom M, Gerhardt H, Kalén M, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001; 153:543-553.
54. Enge M, Bjarnegård M, Gerhardt H, et al. Endothelium-specific plateletderived growth factor-B ablation mimics diabetic retinopathy. EMBO J 2002; 21:4307-4316.
55. Song S, Ewald AJ, Stallcup W, et al. PDGFR beta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005; 7:870-879.
56. Rajkumar VS, Sundberg C, Abraham DJ, et al. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 1999; 42:930-941.
57. Fleischmajer R, Damanio V, Nedwich A. Scleroderma and the subcutaneous tissue. Science 1971; 171:1019-1021.
58. Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112:456-462.
59. Wu M, Melichian DS, Chang E, et al. Rosiglitazone abrogates bleomycininduced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 2009; 174:519-533.
60. Servettaz A, Goulvestre C, Kavian N, et al. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009; 182:5855-5864.
61. Stawski L, Han R, Bujor AM, Trojanowska M. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther 2012; 14:R194.
62. Sonnylal S, Denton CP, Zheng B, et al. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum 2007; 56:334-344.
63. Zhang Y, McCormick LL, Desai SR, et al. Murine sclerodermatous graftversus-host disease, a model for Human Scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002; 168:3088-3098.
64. Maurer B, Distler J, Distler O. The Fra-2 transgenic mouse model of systemic sclerosis. Vascul Pharmacol 2013; 58:194-201.
65. Gerber EE, Gallo EM, Fontana SC, et al. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. Nature 2013; 503:126-130.
66. Manne J, Markova M, Siracusa LD, Jimenez SA. Collagen content in skin and internal organs of the tight skin mouse: an animal model of scleroderma. Biochem Res Int 2013; 2013:436053.
67. Christner PJ, Peters J, Hawkins D, et al. The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum 1995; 38:1791-1798.
68. Wei J, Melichian D, Komura K, et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum 2011; 63:1707-1717.
69. Bochet L, Lehuédé C, Dauvillier S, et al. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 2013; 73:5657-5668.
70. Sun K, Tordjman J, Clément K, Scherer PE. Fibrosis and adipose tissue dysfunction. Cell Metab 2013; 18:470-477.
71. Bing C, Russell S, Becket E, et al. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer 2006; 95:1028-1037.
72. Bing C, Trayhurn P. New insights into adipose tissue atrophy in cancer cachexia. Proc Nutr Soc 2009; 68:385-392.
73. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655-1669.
74. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A 1985; 82:8681-8685.
75. Shi-wen X, Eastwood M, Stratton RJ, et al. Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts. Rheumatology 2009; 49:263-371.
76. Du B, Cawthorn WP, Su A, et al. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling. J Biol Chem 2013; 288:3036-3047.
77. Barak Y, Nelson MC, Ong ES, et al. PPAR is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4:585-595.
78. Wu Z, Rosen ED, Brun R, et al. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 1999; 3:151-158.
79. Farmer SR. Regulation of PPAR-activity during adipogenesis. Int J Obes (Lond) 2005; 29:S13-S16.
80. Boyer B, Tucker GC, Vallés AM, et al. Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int J Cancer Suppl 1989; 4:69-75.
81. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127 (6 Pt 2):2021-2036.
82. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-1784.
83. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial mesenchymal transformation. Am J Physiol 1997; 273 (4 Pt 2):F563-F574.
84. Friedman SL, Sheppard D, Duffield JS. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013; 5:167sr1.